RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Nanotechnology
Jan 2008 - 192 pages - $3,835
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
Feb 2011 - 17 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
CV & Diabetes Market Forecast
Jan 2009 - $15,200
Who's Developing What in Cardiovascular Devices?
Sep 2010 - 412 pages - $1,040
Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients
Nov 2010 - 7 pages - $500
What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
May 2011 - 150 pages - $3,995
Nanotechnology: Players, products & prospects to 2018 (Volume II)
Jun 2009 - 106 pages - $1,040
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Nanotechnology del
Therapeutic target
Cardiovascular del
Treatments del

Browse By

Therapeutic target
Angioplasty
Anti-angiogenesis
Cardioprotection
Cardiovascular surgery
Coronary artery angioplasty/bypass
Percutaneous transluminal angioplasty
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us